BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1668105)

  • 1. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor.
    Ruis NM; Rose JK; Valone FH
    Lipids; 1991 Dec; 26(12):1060-4. PubMed ID: 1668105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor.
    Valone FH; Ruis NM
    Immunology; 1992 May; 76(1):24-9. PubMed ID: 1628897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced human monocyte cytotoxicity by platelet-activating factor.
    Valone FH; Philip R; Debs RJ
    Immunology; 1988 Aug; 64(4):715-8. PubMed ID: 3169845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological response of guinea pig peritoneal macrophages to platelet-activating factor.
    Hayashi H; Kudo I; Nojima S; Inoue K
    Lipids; 1991 Dec; 26(12):1193-9. PubMed ID: 1668117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cells.
    Weber C; Aepfelbacher M; Haag H; Ziegler-Heitbrock HW; Weber PC
    Eur J Immunol; 1993 Apr; 23(4):852-9. PubMed ID: 7681399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine.
    Rose JK; Debs RA; Philip R; Ruis NM; Valone FH
    J Immunol; 1990 May; 144(9):3513-7. PubMed ID: 2329280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor release by murine macrophages stimulated by the cytotoxic ether lipid 1-O-hexadecyl-2-O-methyl-SN-glycero-3-phosphorylcholine (ET-18-O-OCH3).
    Shames R; Ruis NM; Valone FH
    Int J Immunopharmacol; 1994 Apr; 16(4):335-43. PubMed ID: 8045673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented expression of platelet-activating factor receptor gene by TNF-alpha through transcriptional activation in human monocytes.
    Dagenais P; Thivierge M; Parent JL; Stankova J; Rola-Pleszczynski M
    J Leukoc Biol; 1997 Jan; 61(1):106-12. PubMed ID: 9000543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1.
    Proudfoot JM; Croft KD; Puddey IB; Beilin LJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):846-53. PubMed ID: 12626661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
    He J; Bazan HE
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma.
    Valone FH; Epstein LB
    J Immunol; 1988 Dec; 141(11):3945-50. PubMed ID: 3141509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor stimulates receptor-mediated formation of reactive oxygen intermediates in human monocytes.
    Pustynnikov MG; Porodenko NV; Makarova OV; Kozyukov AV; Moskaleva EYu ; Sokolovsky AA; Severin ES
    Lipids; 1991 Dec; 26(12):1214-7. PubMed ID: 1668118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism.
    Frostegård J; Huang YH; Rönnelid J; Schäfer-Elinder L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):963-8. PubMed ID: 9157962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
    Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F
    Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte/macrophage-like U937 cells.
    Korth R; Zimmermann K; Richter WO
    Chem Phys Lipids; 1994 Apr; 70(2):109-19. PubMed ID: 8033283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of platelet-activating factor with interferon-gamma in the stimulation of interleukin-1 production by human monocytes.
    Barthelson R; Valone F
    J Allergy Clin Immunol; 1990 Aug; 86(2):193-201. PubMed ID: 2117030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor.
    Lacasse C; Turcotte S; Gingras D; Stankova J; Rola-Pleszczynski M
    Inflammation; 1997 Apr; 21(2):145-58. PubMed ID: 9187959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor.
    Brewer C; Bonin F; Bullock P; Nault MC; Morin J; Imbeault S; Shen TY; Franks DJ; Bennett SA
    J Neurochem; 2002 Sep; 82(6):1502-11. PubMed ID: 12354298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor.
    Bonavida B; Mencia-Huerta JM; Braquet P
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):157-60. PubMed ID: 2707879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.